Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05818865
NA

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

Sponsor: National Cancer Institute, Naples

View on ClinicalTrials.gov

Summary

This is multicentric, interventional, non farmacological and prospective study.

Official title: "Principle Test" for Isolation and Characterization of Cancer Cells (CTC)-CXCR4+ Circulating in Belotero Loaded With CXCL12 in Patients With Solid Neoplasms (Endometrium, Kidney, Glioblastoma, Colorectal, Ovary and Lung).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

47

Start Date

2021-01-18

Completion Date

2025-12

Last Updated

2025-07-29

Healthy Volunteers

No

Interventions

DEVICE

CLG

The development of an innovative device (CLG) consisting of an aqueous gel based on hyaluronic acid and commercially available (Belotero) able to be loaded and to release chemokine CXCL12 recreating a kind of "fake niche" able to attract immune cells- and CTCs-CXCR4+. The added value is the ability to attract and trap cells capable of leaking out and potentially with a higher metastatic capacity.

Locations (2)

Istitute Nazionale Tumori - Fondazione G. Pascale

Naples, Italy

Istituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS

Naples, Italy